Basivertebral nerve ablation for vertebrogenic low back pain using the OptaBlate BVN system
Official title: A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain
Run by Stryker Instruments · NCT07392333 · Data updated 2026-11-12
This study tests whether using the OptaBlate BVN system to ablate the basivertebral nerve helps people with vertebrogenic low back pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Stryker Instruments Industry-sponsored |
| Locations | 1 site (Fort Lauderdale, Florida) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07392333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing basivertebral nerve ablation with the OptaBlate BVN system at Cantor Spine Center who can consent, read and follow study procedures, and adhere to follow-up.
✕Probably not a fit
Patients with contraindications, prior vertebral interventions at the target levels, obesity (BMI >40), or other exclusion criteria may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of patients undergoing basivertebral nerve ablation with the Stryker OptaBlate BVN system as part of routine care. Participants are followed for 12 months after the procedure to observe outcomes. Eligible patients must be treated according to the device’s instructions for use and provide informed consent. The study aims to document real-world outcomes in a single center and does not assign treatments beyond standard clinical practice. Exclusion criteria include contraindications in the IFU, prior vertebral surgeries or procedures at target levels, obesity, malignancy, recent spine interventions, and other conditions that could affect safety or outcomes.
Why it matters
Potential benefit: If successful, patients could experience relief from vertebrogenic low back pain and improved function after basivertebral nerve ablation.
How similar studies have gone: Early studies in related basivertebral nerve interventions have shown promise, but this exact observational approach with the OptaBlate BVN system is being evaluated in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient scheduled for treatment with the OptaBlate BVN System in accordance with the device IFU and willing to participate in the clinical investigation, undergo study procedure, engage in follow-up, able to read, write, speak, and understand English, and able to provide written informed consent. Exclusion Criteria: * The patient meets one or more contraindications as defined in the locally applicable IFU * Spinal fracture or history of spinal trauma at index levels * Previous lumbar fusion at any level * Prior basivertebral nerve ablation at the target levels * Vertebral cancer, spinal metastasis or Tumor-related vertebral fractures * History of Osteoporotic vertebral fractures * Spine interventions, including epidural steroid injections within 30 days * BMI \> 40 kg/m² * Symptomatic spinal stenosis * Radicular pain or leg pain greater than back pain * Pregnancy or planning pregnancy during study period * Enrollment in another interventional clinical trial * Contraindication to MRI * Life expectancy of less than 12 months
Where it's running
-
Cantor Spine Center
Fort Lauderdale, Florida, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroid Injections for Back and Neck Pain: What Works Best
This study tests different steroid injections and combinations to see what provides the best pain relief and function for adults with back or neck pain.
-
Comparing MILD procedure outcomes for lumbar spinal stenosis patients
This study looks at how well the MILD procedure works for people with lumbar spinal stenosis compared to another treatment, to see which one leads to better outcomes and fewer complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.